Skip to main content
Premium Trial:

Request an Annual Quote

ATCC: Raymond Stapleton

Raymond Stapleton has been appointed as president and chief operating officer of biological materials resource and standards organization ATCC. Previously, he was senior VP of technical operations at Iovance Biotherapeutics, and before that, he held various roles at Merck. Stapleton holds a PhD in microbial ecology from the University of Tennessee and a bachelor's degree in biology from Mary Washington College in Fredericksburg, Virginia.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.